Skye Bioscience, Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Skye Bioscience, Stock Summary

Skye Bioscience, competes with Silo Pharma, Tonix Pharmaceuticals, Jaguar Animal, Vaxart, and Revolution Medicines. Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. Skye Bioscience, Inc. was founded in 2012 and is headquartered in San Diego, California. Skye Bioscience operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 9 people.

Skye Bioscience, Key Financial Ratios

Skye Bioscience, Key Balance Sheet Accounts

Skye Bioscience, Key Income Statement Accounts

Skye Bioscience, Key Cash Accounts

Skye Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Skye Bioscience,'s current stock value. Our valuation model uses many indicators to compare Skye Bioscience, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Skye Bioscience, competition to find correlations between indicators driving Skye Bioscience,'s intrinsic value. More Info.Skye Bioscience, Common is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Skye Bioscience,'s Return On Equity is projected to increase based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Skye Bioscience, by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Skye Bioscience, Common Systematic Risk

Today, most investors in Skye Bioscience, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Skye Bioscience,'s growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Skye Bioscience, growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Skye Bioscience, help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Skye Bioscience, Common. We use our internally-developed statistical techniques to arrive at the intrinsic value of Skye Bioscience, Common based on widely used predictive technical indicators. In general, we focus on analyzing Skye Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Skye Bioscience,'s daily price indicators and compare them against related drivers.

When running Skye Bioscience,'s price analysis, check to measure Skye Bioscience,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Skye Bioscience, is operating at the current time. Most of Skye Bioscience,'s value examination focuses on studying past and present price action to predict the probability of Skye Bioscience,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Skye Bioscience,'s price. Additionally, you may evaluate how the addition of Skye Bioscience, to your portfolios can decrease your overall portfolio volatility.